Each of these characteristics may be available at bedside in parallel of the assessment of infection, organ dysfunction, pro- (for example TNFα and/or IL-18) and anti-inflammatory (for example IL-1Ra and/or IL-10) cytokines, and markers of adaptive function (for example HLA-DR). This evidence concerns the gene TNF and infection.